Bing

SEARCH HISTORY

They set a “strong-buy” rating and a $1.45 price target on the stock. Shares of Hemispherx BioPharma (NYSE:HEB) opened at 0.1973 on Tuesday. Hemispherx BioPharma has a 52 week low of $0.17 and a 52 week high of $0.40. The stock’s 50-day …
Ticker Report · 7/28/2015
PHILADELPHIA, July 27, 2015 (GLOBE NEWSWIRE) -- The Management and the Board of Directors of Hemispherx Biopharma (NYSE MKT:HEB) have announced that the company will host a Stockholder Open House at its Manufacturing and Development …
Financial Content · 7/27/2015
Stockholder Open House
HEB Shares Outstanding data by YCharts Since the company filed an S-3 on 6/25, the stock has dropped more than 10% while the SPDR Biotech ETF is up 1%. At the 2014 Annual Meeting, shareholders voted down the executive compensation with only …
Seeking Alpha · 7/14/2015
More from Bing News
BOSTON (TheStreet) -- The latest Biotech Stock Mailbag tackles the hepatitis C fallout ... writes, "Your article may be enough to lower Hemispherx Biopharma's (HEB) stock price to where I'll want to add to my holdings. New price target is $3.
The Street · ByAdam Feuerstein · 2/6/2015
You can find the HEB's that carry our breads, cookies and mixes by clicking below. But they will only carry stock while they last. We will no longer be supplying new stock. Thank you again for your support, and all the …
San Antonio Current · 7/28/2015
In addition, HEB has announced plans to build a grocery store essentially ... A FORTUNE 1,000 company, Los Angeles-based KB Home was the first homebuilder listed on the New York Stock Exchange, and trades under the ticker symbol "KBH."
Wallstreet online · 7/30/2015
Our common stock is listed on the NYSE MKT under the ticker symbol "HEB". Sales of shares of our common stock under this prospectus supplement and the accompanying prospectus, if any, may be made by any method permitted by law deemed to be …
Benzinga · ByPaul Quintaro · 3/6/2015
Hemispherx Biopharma, Inc. (HEB) of the Healthcare sector lost -1.03%, a change from open of -1.37% ($0.00 per share) at mid-day Monday with a volume of 695008 shares. Hemispherx Biopharma, Inc. (HEB) is up $0.29, with a weekly performance of .
wallstreetscope.com · 11/11/2014
Biotech companies with experimental Ebola vaccines continue to perform well on the stock market. Inovio Pharmaceuticals Inc (INO) and Hemispherx BioPharma, Inc (HEB) are also part of the list. NewLink is working on an Ebola preventive vaccine that was ...
bidnessetc.com · 10/3/2014
Based on his own research, he’s found that if HEB stocks inexpensive children’s books—mostly Golden Books and paperbacks—people will buy. “Literacy for me is important, because I love my company and the future for any company is having an ...
Publishers Weekly · ByJudith Rosen · 9/2/2010